Decoding the regulatory landscape of medulloblastoma using DNA methylation sequencing
暂无分享,去创建一个
David T. W. Jones | R. Eils | G. Reifenberger | M. Kool | H. Lehrach | V. Hovestadt | N. Jäger | P. Northcott | P. Lichter | S. Pfister | M. Sultan | M. Yaspo | B. Brors | S. Picelli | A. Borkhardt | R. Versteeg | P. Landgraf | C. Lawerenz | A. Korshunov | O. Witt | J. Koster | S. Wolf | H. Warnatz | R. Wechsler-Reya | Michael D. Taylor | T. Pietsch | S. Rutkowski | J. Eils | K. Kleinheinz | S. Erkek | U. D. Weber | M. Zapatka | B. Radlwimmer | W. Scheurlen | J. Felsberg | M. Ralser | C. Bartholomae | T. Milde | M. Ryzhova | S. Schmidt | J. Bunt | Wei Wang | C. Kalle | K. Stachurski | S. Brun | Sonja N. Brun | Ursula D. Weber | Sabine Schmidt
[1] Wei Li,et al. Large conserved domains of low DNA methylation maintained by Dnmt3a , 2013, Nature Genetics.
[2] Matthew D. Schultz,et al. Global Epigenomic Reconfiguration During Mammalian Brain Development , 2013, Science.
[3] Roland Eils,et al. Recurrent somatic alterations of FGFR1 and NTRK2 in pilocytic astrocytoma , 2013, Nature Genetics.
[4] Michael B. Stadler,et al. Identification of active regulatory regions from DNA methylation data , 2013, Nucleic acids research.
[5] C. Hawkins,et al. FoxG1 Interacts with Bmi1 to Regulate Self‐Renewal and Tumorigenicity of Medulloblastoma Stem Cells , 2013, Stem cells.
[6] Michael Q. Zhang,et al. Epigenomic Analysis of Multilineage Differentiation of Human Embryonic Stem Cells , 2013, Cell.
[7] Volker Hovestadt,et al. Robust molecular subgrouping and copy-number profiling of medulloblastoma from small amounts of archival tumour material using high-density DNA methylation arrays , 2013, Acta Neuropathologica.
[8] G. Daley,et al. Lin28: primal regulator of growth and metabolism in stem cells. , 2013, Cell stem cell.
[9] Peter W. Laird,et al. Interplay between the Cancer Genome and Epigenome , 2013, Cell.
[10] Juan M. Vaquerizas,et al. DNA-Binding Specificities of Human Transcription Factors , 2013, Cell.
[11] Thomas R. Gingeras,et al. STAR: ultrafast universal RNA-seq aligner , 2013, Bioinform..
[12] R. Spang,et al. Recurrent mutation of the ID3 gene in Burkitt lymphoma identified by integrated genome, exome and transcriptome sequencing , 2012, Nature Genetics.
[13] Scott L. Pomeroy,et al. Medulloblastomics: the end of the beginning , 2012, Nature Reviews Cancer.
[14] R. Stallings,et al. LIN28B induces neuroblastoma and enhances MYCN levels via let-7 suppression , 2012, Nature Genetics.
[15] Stefan M. Pfister,et al. HD-MB03 is a novel Group 3 medulloblastoma model demonstrating sensitivity to histone deacetylase inhibitor treatment , 2012, Journal of Neuro-Oncology.
[16] Matthew J. Betts,et al. Dissecting the genomic complexity underlying medulloblastoma , 2012, Nature.
[17] B. Schuster-Böckler,et al. Chromatin organization is a major influence on regional mutation rates in human cancer cells , 2012, Nature.
[18] Jan Koster,et al. OTX2 directly activates cell cycle genes and inhibits differentiation in medulloblastoma cells , 2012, International journal of cancer.
[19] Brian J. Stevenson,et al. Global DNA hypomethylation coupled to repressive chromatin domain formation and gene silencing in breast cancer. , 2012, Genome research.
[20] P. Laird,et al. Regions of focal DNA hypermethylation and long-range hypomethylation in colorectal cancer coincide with nuclear lamina–associated domains , 2011, Nature Genetics.
[21] Vijay K. Tiwari,et al. DNA-binding factors shape the mouse methylome at distal regulatory regions , 2011, Nature.
[22] Scott L. Pomeroy,et al. Molecular subgroups of medulloblastoma: the current consensus , 2011, Acta Neuropathologica.
[23] D. Zwijnenburg,et al. Joint Binding of OTX2 and MYC in Promotor Regions Is Associated with High Gene Expression in Medulloblastoma , 2011, PloS one.
[24] S. Rafii,et al. Directional DNA methylation changes and complex intermediate states accompany lineage specificity in the adult hematopoietic compartment. , 2011, Molecular cell.
[25] A. Feinberg,et al. Increased methylation variation in epigenetic domains across cancer types , 2011, Nature Genetics.
[26] Felix Krueger,et al. Bismark: a flexible aligner and methylation caller for Bisulfite-Seq applications , 2011, Bioinform..
[27] J. Mesirov,et al. Integrative genomic analysis of medulloblastoma identifies a molecular subgroup that drives poor clinical outcome. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[28] R. Stewart,et al. Hotspots of aberrant epigenomic reprogramming in human induced pluripotent stem cells , 2011, Nature.
[29] D. Aran,et al. Replication timing-related and gene body-specific methylation of active human genes. , 2011, Human molecular genetics.
[30] Ana Kozomara,et al. miRBase: integrating microRNA annotation and deep-sequencing data , 2010, Nucleic Acids Res..
[31] Cole Trapnell,et al. Transcript assembly and quantification by RNA-Seq reveals unannotated transcripts and isoform switching during cell differentiation. , 2010, Nature biotechnology.
[32] Martin J Aryee,et al. Differential methylation of tissue- and cancer-specific CpG island shores distinguishes human induced pluripotent stem cells, embryonic stem cells and fibroblasts , 2009, Nature Genetics.
[33] Lee E. Edsall,et al. Human DNA methylomes at base resolution show widespread epigenomic differences , 2009, Nature.
[34] Richard Durbin,et al. Sequence analysis Fast and accurate short read alignment with Burrows – Wheeler transform , 2009 .
[35] A. Feinberg,et al. Genome-wide methylation analysis of human colon cancer reveals similar hypo- and hypermethylation at conserved tissue-specific CpG island shores , 2008, Nature Genetics.
[36] A. Feinberg,et al. Large histone H3 lysine 9 dimethylated chromatin blocks distinguish differentiated from embryonic stem cells , 2009, Nature Genetics.
[37] Cole Trapnell,et al. Ultrafast and memory-efficient alignment of short DNA sequences to the human genome , 2009, Genome Biology.
[38] Clifford A. Meyer,et al. Model-based Analysis of ChIP-Seq (MACS) , 2008, Genome Biology.
[39] Robert Machold,et al. Medulloblastoma can be initiated by deletion of Patched in lineage-restricted progenitors or stem cells. , 2008, Cancer cell.
[40] Jeffrey D. Zaremba,et al. Transcription factor MEF2C influences neural stem/progenitor cell differentiation and maturation in vivo , 2008, Proceedings of the National Academy of Sciences.
[41] Thomas Tuschl,et al. Identification of microRNAs and other small regulatory RNAs using cDNA library sequencing. , 2008, Methods.
[42] K. Aldape,et al. Epigenome scans and cancer genome sequencing converge on WNK2, a kinase-independent suppressor of cell growth , 2007, Proceedings of the National Academy of Sciences.
[43] Anne H. O'Donnell,et al. Hyperconserved CpG domains underlie Polycomb-binding sites , 2007, Proceedings of the National Academy of Sciences.
[44] Zohar Yakhini,et al. Polycomb-mediated methylation on Lys27 of histone H3 pre-marks genes for de novo methylation in cancer , 2007, Nature Genetics.
[45] Kelly M. McGarvey,et al. A stem cell–like chromatin pattern may predispose tumor suppressor genes to DNA hypermethylation and heritable silencing , 2007, Nature Genetics.
[46] Janet L Stein,et al. Canonical WNT Signaling Promotes Osteogenesis by Directly Stimulating Runx2 Gene Expression* , 2005, Journal of Biological Chemistry.
[47] Pablo Tamayo,et al. Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles , 2005, Proceedings of the National Academy of Sciences of the United States of America.